CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer

BACKGROUND: (V600E)BRAF mutated metastatic colorectal cancer (mCRC) is a subtype (10%) with overall poor prognosis, but the clinical experience suggests a great heterogeneity in survival. It is still unexplored the real distribution of traditional and innovative biomarkers among (V600E)BRAF mutated...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Cancer
Hlavní autoři: Loupakis, Fotios, Biason, Paola, Prete, Alessandra Anna, Cremolini, Chiara, Pietrantonio, Filippo, Pella, Nicoletta, Dell’Aquila, Emanuela, Sperti, Elisa, Zichi, Clizia, Intini, Rossana, Dadduzio, Vincenzo, Schirripa, Marta, Bergamo, Francesca, Antoniotti, Carlotta, Morano, Federica, Cortiula, Francesco, De Maglio, Giovanna, Rimassa, Lorenza, Smiroldo, Valeria, Calvetti, Lorenzo, Aprile, Giuseppe, Salvatore, Lisa, Santini, Daniele, Munari, Giada, Salmaso, Roberta, Guzzardo, Vincenza, Mescoli, Claudia, Lonardi, Sara, Rugge, Massimo, Zagonel, Vittorina, Di Maio, Massimo, Fassan, Matteo
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6889398/
https://ncbi.nlm.nih.gov/pubmed/31474758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0560-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky